Dyspareunia Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Phase 2
Topical Ketotifen 0.25% for Secondary Vestibulodynia
VulvodyniaProvoked VestibulodyniaSecondary Provoked Vestibulodynia+4 more
Center for Vulvovaginal Disorders54 enrolled3 locationsNCT07257029
Recruiting
Not Applicable
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
DyspareuniaVestibulodyniaPelvic Pain+3 more
Medstar Health Research Institute60 enrolled1 locationNCT06840314